Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-08T03:28:13.709Z Has data issue: false hasContentIssue false

Immune dysfunction, depression and neurodegeneration

Published online by Cambridge University Press:  24 June 2014

B. E. Leonard
Affiliation:
Department of Psychiatry and Psychotherapy, Laboratory of Psychoneuroimmunology, University Psychiatric Hospital, Ludwig Maximilians University, Munich, Germany Department of Pharmacology, National University of Ireland, Galway
A. M. Myint
Affiliation:
Department of Psychiatry and Psychotherapy, Laboratory of Psychoneuroimmunology, University Psychiatric Hospital, Ludwig Maximilians University, Munich, Germany

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Psychoimmunology Symposium: The Impact of Dysfunctional Endocrine and Immune Systems on Psychiatric Disorders
Copyright
Copyright © 2009 John Wiley & Sons A/S

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References:

1.Wichers, MC, Kenis, G, Koch, GH, Robaegs, G, Nicolson, NA, Maes, M. Interferon apha induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res 2007;62:207214.CrossRefGoogle Scholar
2.A-M, Myint, Leonard, BE, Steinbusch, H, Y-K, Kim. Th1, Th2 and Th3 cytokine alterations in major depression. J Affect Dis 2005;88:169173.Google Scholar
3.Minami, M, Kuraishi, Y, Yamaguchi, T, Nalai, S, Hirai, Y, Satoh, M.Immobilisation stress induces IL-1 beta nRNA in the rat hypothalamus. Neurosci Lett 1991;123:254256.CrossRefGoogle Scholar
4.Shintani, F, Nakaki, T, Kanba, S, Asai, M.Role of IL-1 in stress responses.A putative neurotransmitter. Mol Neurobiol 1995;10:4771.CrossRefGoogle ScholarPubMed
5.Persoons, JH, Schormagel, K, Breve, J, Berlkenbosch, F, Kraal, G.Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently. Am J Respir Crit Care Med 1995;152:619624.CrossRefGoogle ScholarPubMed
6.Zhou, D, Kusnecov, AW, Shurin, MR, De Paoli, M, Rabin, BS.Exposure to physical and psychological stressors elevates plasma IL-6: relationship to the activation of HPA axis. Endocrinol 1993;133:25232530.CrossRefGoogle Scholar
7.Shizuya, K, Komori, T, Fujiwara, R, Miyahara, S, Ohmori, M, Nomura, J.Influence of restraint stress on the expression of mRNA for IL6 and IL-6 receptor in the hypothalamus and mid brain. Life Sci 1997;61:135140.CrossRefGoogle Scholar
8.Song, C, Leonard, BE.The olfactory bulbectomised rat model of depression. Neurosci Biobehav Rev 2005;29:627647.CrossRefGoogle ScholarPubMed
9.Maes, M. Major depression and activation of the inflammatory response. Adv Exp Biol Med 1999;461:2546.CrossRefGoogle ScholarPubMed
10.Holsboer, F. The rationale for CRH receptor antagonists to treat depression and anxiety. J Psychiat Res 1999;33:181214.CrossRefGoogle ScholarPubMed
11.Leonard, BE, A-M, Myint. Inflkammation and depression: is there a causal connection with dementia?. Neurotox Res 2006;10:149160.CrossRefGoogle Scholar
12.Geerlings, MI, Schoevers, RA, Beckman, AT.Depression and rik of cognitive decline and Alzheimer's disease. Results oftwo prospective community based studies in the Netherlands. Br J Psychiat 2000;176:568575.CrossRefGoogle Scholar
13.Chen, P, Ganguli, M, Mulsant, BH, DeKosky, ST.The temporal relationship between depressive symptoms and dementia. Arch Gen Psychiat 1999;56:261266.CrossRefGoogle ScholarPubMed
14.Nibuya, M, Takahashi, M, Russell, DS, Duman, RS.Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 1999;267:8184.CrossRefGoogle ScholarPubMed
15.A-M, Myint, Y-K, Kim. Cytokine-serotonin interaction through indoleamine dioxygenase: a neurodegenerative hypothesis of depression. Med Hypoth 2003;61:8184.Google Scholar
16.Chiarrugi, A, Calvani, M, Meli, E, Traggiai, F.Synthesis and release of neurotoxic kynurenine metabolites by human monocyte derived macrophages. J Neuroimmunol 2001;120:190198.CrossRefGoogle Scholar
17.Guillemin, GJ, Smith, DG, Kerr, SJ, Smythe, GA, Kapoor, V, Armati, PJ. Characterisation of the kymurenine pathway metaboilism in human astrocytes and implications in neuro-pathogenesis. Redox Rep 2000;5:108111.CrossRefGoogle Scholar
18.Guillemin, GJ, Kerr, SJ, Smythe, GA, Smith, DG, Kapoor, V, Armali, PJ. Kynurenine pathway metabolism in human astro-cytes: a paradox for neuronal protection. J Neurochem 2001;78:842853.CrossRefGoogle ScholarPubMed
19.A-M, Myint, Y-K, Kim, Verkerk, R, Scharpe, S, Steinbusch, H, Leonard, BE.Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Dis 2007;98:143151.Google Scholar
20.De La Garga, R. Endotoxin or proinflammatory cytokine induced sickness behaviour as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev 2005;29:761770.CrossRefGoogle Scholar
21.Leonard, BE. Inflammation.depression and dementia:are they connected? Neurochem Res 2007;32:17491756.CrossRefGoogle Scholar